English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Preplanned dose titrations are sometimes used in clinical trials to improve patient tolerability to treatment. Such titrations often start from a low dose and gradually increase to the targeted dose, and therefore, the low-dose and high-dose arms may share the same dose for a certain period of time. Traditionally, the analysis has been performed according to the treatment arm, ignoring the fact that there are overlapping initial doses between arms. This article describes an alternative method of analysis that exploits the design feature on titrations to produce a more efficient estimation for the mean response over time for each treatment regimen as well as the comparison between treatment regimens for continuous, time-to-event, binary, and count variables. For continuous and count data, we used the (generalized) linear mixed model framework to construct the new estimators; for time-to-event data, we developed a novel logrank test; and for the binary variable, we derived the point and variance estimators based on the events that occurred in each study period. Simulation studies and the application to a real clinical dataset demonstrate the newly proposed approach is advantageous over the traditional approach.

Efficient Estimation of the Efficacy and Safety Endpoints for Clinical Trials with Preplanned Dose Titrations